Invention Grant
- Patent Title: Synergistic famciclovir and celecoxib combination therapy for functional somatic syndromes
-
Application No.: US15820773Application Date: 2017-11-22
-
Publication No.: US10251853B2Publication Date: 2019-04-09
- Inventor: William L. Pridgen
- Applicant: INNOVATIVE MED CONCEPTS, LLC
- Applicant Address: US AL Tuscaloosa
- Assignee: INNOVATIVE MED CONCEPTS, LLC
- Current Assignee: INNOVATIVE MED CONCEPTS, LLC
- Current Assignee Address: US AL Tuscaloosa
- Agency: Harness, Dickey & Pierce, P.L.C.
- Main IPC: A61K31/196
- IPC: A61K31/196 ; A61K31/635 ; A61K31/52 ; A61K31/522 ; A61K31/5415 ; A61K31/415 ; A61K31/427 ; A61K31/5575 ; A61K45/06
Abstract:
The present invention relates to methods of treating fibromyalgia, by administering a therapeutically-effective combination of an antiviral component and a COX-2 inhibitor component. The invention is further related to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound famciclovir and a therapeutically-effective amount of the COX-2 inhibitor celecoxib. The invention is also related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of famciclovir and celecoxib.
Public/Granted literature
- US20180125804A1 SYNERGISTIC FAMCICLOVIR AND CELECOXIB COMBINATION THERAPY FOR FUNCTIONAL SOMATIC SYNDROMES Public/Granted day:2018-05-10
Information query
IPC分类:
